Implementation of Substance Use Treatment in Ambulatory Care

Teaches medical providers how to recognize and manage aberrant behaviors in patients taking prescription opioids, such as drug misuse or diversion; how to terminate opioid treatment and transition patients to alternative types of care; and how to manage disruptive or threatening patient behaviors that may arise when discontinuing opioids.

Helps clinicians screen their patients for SUDs, conduct brief interventions for patients in the early stages of problem development, and appropriately refer more severely affected patients for indepth assessment and treatment.

Gives clinicians information about treating pregnant women with buprenorphine.

Provides information for treating pregnant and parenting women with OUD, as well as their infants.

Describes the nature and dimensions of OUDs and their treatment, consensus panel recommendations and evidence-based best practices for opioid treatment programs (OTPs), related co-occurring disorders and their treatment, and ethical considerations that arise in most OTPs.

Provides guidance on the use of buprenorphine among a number of topics, including physiology and pharmacology of opioids, opioid addiction, and buprenorphine treatment; screening and assessment of OUDs; protocols for buprenorphine treatment; management of special populations; and policies and procedures related to DATA 2000.

Offers guidelines for MAT for individuals, particularly veterans, with PTSD and co-occurring OUDs. Covers screening, concomitant treatment, pharmacotherapy, and multiple substances of abuse.

Provides an overview of the key points of the National Practice Guideline, detailed recommendations for OUD diagnosis, and information on treatment settings and opioid withdrawal. Describes MAT options and considerations for treating special populations. Links to additional resources, such as a pocket guide and a slide deck.

Describes what physicians need to know about the patient limit of 275, such as eligibility and credentials.

Provides a high-level overview of the potential for buprenorphine abuse and how to reduce the risks.